Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors

Clinical trial NCT05599048 · RECRUITING

Trial details

NCT number: NCT05599048
Sponsor: Robert Bok, MD, PhD
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-12-15
Primary completion: 2027-01-31
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.